Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Genmab a::S symbols : BNTX save search
Genmab Announces Financial Results for the First Nine Months of 2023
Published: 2023-11-07 (Crawled : 16:00) - globenewswire.com
GNMSF | News | $289.67 3.83% 5.3K
|
Health Technology
|
| O: 0.39%
H: 4.92%
C: 1.52%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.24%
H: 0.18%
C: 0.16%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
GMAB | News | $28.54 -1.48% -1.51% 560K
|
Health Technology
|
| O: 0.24%
H: 3.44%
C: 2.07%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -0.35%
H: 3.09%
C: 3.03%
financial results
BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
Published: 2023-11-06 (Crawled : 12:00) - globenewswire.com
GNMSF | News | $289.67 3.83% 5.3K
|
Health Technology
|
| O: 0.24%
H: 3.29%
C: -1.11%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.19%
H: 0.29%
C: -0.45%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
GMAB | News | $28.54 -1.48% -1.51% 560K
|
Health Technology
|
| O: 0.55%
H: 0.44%
C: -1.37%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: 5.74%
H: 3.18%
C: -1.55%
update financial results
Genmab Announces Financial Results for the First Half of 2023
Published: 2023-08-03 (Crawled : 15:00) - globenewswire.com
GNMSF | News | $289.67 3.83% 5.3K
|
Health Technology
|
| O: 0.24%
H: 1.29%
C: 1.29%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -0.28%
H: 0.27%
C: 0.06%
GMAB | News | $28.54 -1.48% -1.51% 560K
|
Health Technology
|
| O: -2.25%
H: 1.87%
C: 1.52%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -0.25%
H: 3.13%
C: 1.84%
financial results
Genmab Announces Financial Results for the First Quarter of 2023
Published: 2023-05-10 (Crawled : 14:20) - globenewswire.com
GNMSF | News | $289.67 3.83% 5.3K
|
Health Technology
|
| O: 0.92%
H: 0.54%
C: -0.64%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: -1.24%
H: 0.0%
C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -1.03%
H: 0.26%
C: 0.01%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.09%
H: 0.48%
C: 0.28%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -0.21%
H: 0.32%
C: -0.07%
GMAB | News | $28.54 -1.48% -1.51% 560K
|
Health Technology
|
| O: 0.15%
H: 2.12%
C: 1.79%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -1.6%
H: 1.64%
C: -0.39%
financial results
BioNTech Announces Second Quarter 2022 Financial Results and Corporate Update
Published: 2022-08-08 (Crawled : 11:00) - biospace.com/
GNMSF | News | $289.67 3.83% 5.3K
|
Health Technology
|
| O: 1.97%
H: 0.56%
C: -2.26%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
GMAB | News | $28.54 -1.48% -1.51% 560K
|
Health Technology
|
| O: -0.09%
H: 0.83%
C: 0.26%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -8.8%
H: 2.35%
C: 1.38%
MTNB | $0.1815 0.83% -0.61% 770K
|
Health Technology
|
| O: -3.3%
H: 5.11%
C: 5.11%
update results
BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates
Published: 2022-08-05 (Crawled : 11:00) - globenewswire.com
GNMSF | News | $289.67 3.83% 5.3K
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: -2.02%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.16%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
GMAB | News | $28.54 -1.48% -1.51% 560K
|
Health Technology
|
| O: -2.5%
H: 0.66%
C: 0.11%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -0.45%
H: 3.04%
C: 1.94%
global immunotherapy collaboration
Genmab and BioNTech Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates
Published: 2022-08-05 (Crawled : 11:00) - globenewswire.com
GNMSF | News | $289.67 3.83% 5.3K
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: -2.02%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.16%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
GMAB | News | $28.54 -1.48% -1.51% 560K
|
Health Technology
|
| O: -2.5%
H: 0.66%
C: 0.11%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -0.45%
H: 3.04%
C: 1.94%
global immunotherapy collaboration
Genmab Announces Abstracts Evaluating Investigational Solid Tumor Therapies to be Presented at the Society for Immunotherapy of Cancer’s 36th Annual Meeting (SITC 2021)
Published: 2021-10-01 (Crawled : 12:15) - globenewswire.com
GNMSF | News | $289.67 3.83% 5.3K
|
Health Technology
|
| O: 3.86%
H: 0.57%
C: 0.57%
GMAB | News | $28.54 -1.48% -1.51% 560K
|
Health Technology
|
| O: -1.01%
H: 0.42%
C: -0.23%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -8.06%
H: 3.28%
C: 1.51%
immunotherapy therapy cancer solid tumors
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.